Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Kostopoulos I, Arapantoni-Dadioti P, Gogas H, Papadopoulos S, Malamou-Mitsi V, Scopa CD, Markaki S, Karagianni E, Kyriakou V, Margariti A, Kyrkou E, Pavlakis K, Zaramboukas T, Skordalaki A, Bourli A, Markopoulos C, Pectasides D, Dimopoulos MA, Skarlos D, Fountzilas G.
Kostopoulos I, et al. Among authors: fountzilas g.
Breast Cancer Res Treat. 2006 Apr;96(3):251-61. doi: 10.1007/s10549-005-9062-2.
Breast Cancer Res Treat. 2006.
PMID: 16538542
Clinical Trial.